STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

FRIEDREICHS ATAXIA RESEARCH ALLIANCE FARA: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization
FRIEDREICHS ATAXIA RESEARCH ALLIANCE FARA (EIN 52-2122720)
Tax period
2018-01-01 to 2018-12-31
Filed
2019-05-15
IRS object ID
201941359349303029
Schema version
2018v3.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2019-05-15T09:35:33-05:00ReturnTs
Tax Period End2018-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN231518888PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1MAILLIE LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1624 WILLOWBROOK LANEAddressLine1Txt
CityWEST CHESTERCityNm
State AbbreviationPAStateAbbreviationCd
ZIP19382ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2018-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN522122720EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1FRIEDREICH'S ATAXIA RESEARCH ALLIANCEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlFRIEBusinessNameControlTxt
Phone4848796160PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO BOX 1537AddressLine1Txt
CitySPRINGFIELDCityNm
State AbbreviationVAStateAbbreviationCd
ZIP22151ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonJENNIFER FARMERPersonNm
Person TitleEXECUTIVE DIRECTORPersonTitleTxt
Phone4848796160PhoneNum
Signature2019-05-14SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonEDWARD FRONCZKOWSKI CPAPreparerPersonNm
PTINP01259092PTIN
Phone6106964353PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address96.227.130.2IPv4AddressTxt
FieldValueIRS element (for citing)
IP2019-05-14IPDt
IP Tm11:23:22IPTm
IP TimezoneEDIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device Id15A7E9B0F4D4D3BE77214A119BF6377A745EC461AtSubmissionCreationDeviceId
At Submission Filing Device Id15A7E9B0F4D4D3BE77214A119BF6377A745EC461AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2018TaxYr
Build TS2019-02-21 02:37:17ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJENNIFER FARMERPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1533 W UWCHLAN AVENUEAddressLine1Txt
CityDOWNINGTOWNCityNm
State AbbreviationPAStateAbbreviationCd
ZIP19335ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$8,823,419GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.CUREFA.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1998FormationYr
Legal Domicile StateVALegalDomicileStateCd
Activity Or MissionTO TREAT AND CURE FRIEDREICH'S ATAXIA BY ADVANCING RESEARCH, AWARENESS AND PARTNERSHIPS.ActivityOrMissionDesc
Voting Members Governing Body18VotingMembersGoverningBodyCnt
Voting Members Independent16VotingMembersIndependentCnt
Total Employee13TotalEmployeeCnt
Total Volunteers500TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$7,518,776PYContributionsGrantsAmt
CY Contributions Grants$7,662,625CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$53,104PYInvestmentIncomeAmt
CY Investment Income$40,534CYInvestmentIncomeAmt
PY Other Revenue-$38,343PYOtherRevenueAmt
CY Other Revenue-$99,614CYOtherRevenueAmt
PY Total Revenue$7,533,537PYTotalRevenueAmt
CY Total Revenue$7,603,545CYTotalRevenueAmt
PY Grants And Similar Paid$5,824,049PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$6,078,662CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$605,722PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$665,841CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$109,905CYTotalFundraisingExpenseAmt
PY Other Expenses$382,043PYOtherExpensesAmt
CY Other Expenses$305,349CYOtherExpensesAmt
PY Total Expenses$6,811,814PYTotalExpensesAmt
CY Total Expenses$7,049,852CYTotalExpensesAmt
PY Revenues Less Expenses$721,723PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$553,693CYRevenuesLessExpensesAmt
Total Assets BOY$4,852,978TotalAssetsBOYAmt
Total Assets EOY$5,108,402TotalAssetsEOYAmt
Total Liabilities BOY$323,194TotalLiabilitiesBOYAmt
Total Liabilities EOY$130,166TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$4,529,784NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$4,978,236NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTO MARSHAL AND FOCUS THE RESOURCES AND RELATIONSHIPS NEEDED TO CURE FA BY RAISING FUNDS FOR RESEARCH, PROMOTING PUBLIC AWARENESS AND ALIGNING SCIENTISTS, PATIENTS, CLINICIANS, GOV'T AGENCIES AND PHARMACEUTICAL COMPANIES DEDICATED TO CURING FA AND RELATED DISORDERS.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$5,626,474ExpenseAmt
Grant$5,374,421GrantAmt
DescRESEARCH AND GRANT PROGRAMFARA AWARDED A TOTAL AMOUNT OF $6.1 MILLION IN RESEARCH FUNDING IN 2018 - AN 5.2% INCREASE FROM LAST YEAR. INCREASED FUNDRAISING MADE IT POSSIBLE FOR FARA TO AWARD NEW GRANTS ACROSS SEVERAL AREAS OF STRATEGIC IMPORTANCE. DURING 2018, FARA RECEIVED 37 LETTERS OF INTENT (LOIS) AND INVITED 26 INVESTIGATORS TO SUBMIT NEW RESEARCH GRANT APPLICATIONS. FOLLOWING THE PEER-REVIEW PROCESS, 17 WERE AWARDED FUNDING IN THE FOLLOWING STRATEGIC INITIATIVES: DRUG DISCOVERY (4), GENE AND STEM CELL THERAPY (1), MECHANISMS OR PATHWAY OF DISEASE (3), CELL AND ANIMAL MODELS (3), OUTCOME MEASURES AND BIOMARKERS (4), CARDIAC RESEARCH (1) AND CLINICAL RESEARCH FELLOWSHIP (1). THE SUCCESSFUL INVESTIGATORS WERE FROM 8 DIFFERENT COUNTRIES AND 8 OF THEM (3 OF WHOM WERE JUNIOR INVESTIGATORS) HAD NOT PREVIOUSLY SUBMITTED APPLICATIONS TO FARA. CONTINUATION FUNDING FOR A SECOND YEAR WAS GIVEN TO AN ADDITIONAL 18 RESEARCH PROJECTS AND FARA ALSO PROVIDED ONGOING RESEARCH FUNDING FOR THE COLLABORATIVE CLINICAL RESEARCH NETWORK IN FA (CCRN), THE FA CENTER OF EXCELLENCE, BIOMARKER DEVELOPMENT CONSORTIA AND CLINICAL RESEARCH INFRASTRUCTURE TO FACILITATE CLINICAL TRIALS. ALL OF THESE RESEARCH PROJECTS ADVANCE FA RESEARCH PROVIDING A DEEPENING OUR UNDERSTANDING OF DISEASE MECHANISM, PATHOLOGY, AND PROGRESSION AND DISCOVERY OF INNOVATIVE APPROACHES TO THERAPY. SEVERAL OF THESE GRANTS WERE CO-FUNDED WITH OUR FA ADVOCACY GROUP PARTNERS; THIS COLLABORATIVE APPROACH BOTH INCREASES THE NUMBER OF AVAILABLE RESEARCH DOLLARS AND HELPS TO MINIMIZE DUPLICATION OF EFFORT.FRIEDREICH'S ATAXIA CENTER OF EXCELLENCE, PHILADELPHIA PATHE FA CENTER OF EXCELLENCE (COE) IS A TRANSLATIONAL RESEARCH AND CLINICAL CARE CENTER DEVOTED TO FRIEDREICH ATAXIA: EXPEDITING BASIC SCIENCE AND DRUG DISCOVERY FINDINGS TO NEW TREATMENTS AND DEDICATING RESOURCES TO CLINICAL RESEARCH AND CARE TO FURTHER UNDERSTAND THE DISEASE, INFORM DRUG DEVELOPMENT AND IMPROVE OUTCOMES FOR INDIVIDUALS LIVING WITH FA. THE CENTER WAS ESTABLISHED IN MARCH 2014, WITH A COMMITMENT OF $3.25 MILLION (OVER 3 YEARS) TO PENN MEDICINE/ CHILDREN'S HOSPITAL OF PHILADELPHIA, PRESENTED BY FARA IN PARTNERSHIP WITH THE HAMILTON AND FINNERAN FAMILIES. THE COE ESTABLISHED RESEARCH INFRASTRUCTURE CONSISTING OF FOUR CORE AREAS- NEUROLOGY, CARDIAC, BIOMARKER AND DRUG DISCOVERY. THE CENTER NOT ONLY SUPPORTS WORK WITHIN THESE DISCIPLINES, BUT ALSO FOSTERS EFFICIENT COLLABORATION AND SYNERGY ACROSS THEM. IN ITS FIRST FIVE YEARS, THE COE REACHED SEVERAL SIGNIFICANT RESEARCH MILESTONES WITH THE DISCOVERY OF POSSIBLE TREATMENT CANDIDATES, THE STUDY OF NEW BIOMARKERS TO MEASURE THE DISEASE, AND LAUNCH OF PROMISING NEUROLOGIC AND CARDIAC CLINICAL TRIALS AND STUDIES. IN 2017, THAT COMMITMENT WAS RENEWED FOR AN ADDITIONAL THREE YEARS ($1,403,500 IN 2017, $1,225,500 IN 2018 AND $1,122,000 IN 2019). PROJECTS AND INVESTIGATORS BEING FUNDED INCLUDE DR. ROB WILSON- DRUG DISCOVERY, DR. DAVID LYNCH- TRANSLATIONAL AND CLINICAL NEUROSCIENCE RESEARCH, DR, IAN BLAIR- BIOMARKER DISCOVERY, DR. KIM LIN- CARDIAC RESEARCH AND DR. SHANA MCCORMACK- METABOLISM AND ENDOCRINOLOGY.OF NOTE, FA SHARES SIMILAR SYMPTOMS AND DISEASE MECHANISMS WITH OTHER DISEASES, BOTH RARE AND COMMON. RESEARCH INTO FA IS PROVIDING INSIGHTS AND ADVANCES IN OTHER DISEASES SUCH AS MITOCHONDRIAL DISEASES, MUSCULAR DYSTROPHIES, DIABETES, AND CARDIOMYOPATHY. A COMPLETE LIST OF 2018 FUNDED GRANTS CAN BE FOUND AT: CUREFA.ORG/GRANT-AWARDSA COMPLETE LIST OF 2018 PUBLICATIONS OF RESEARCH FUNDED BY FARA CAN BE FOUND AT: CUREFA.ORG/SCIENTIFIC-NEWS/FUNDED-RESEARCHDesc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$150,510ExpenseAmt
Grant$5,000GrantAmt
DescRESEARCH CONFERENCESFARA ORGANIZES AND SUPPORTS A NUMBER OF CONFERENCES TO IMPROVE SHARING OF KNOWLEDGE, INSIGHTS AND ADVANCES AND BUILD COLLABORATIONS AND SYNERGISTIC CONNECTIONS BETWEEN FA RESEARCHERS, INDUSTRY AND GOVERNMENT PARTNERS AND PATIENTS. BIOMARKER MEETINGFARA HELD ITS THIRD BIOMARKER MEETING IN TAMPA FLORIDA ON SEPTEMBER 28TH, 2018. SESSIONS COVERED FRATAXIN AND METABOLIC BIOMARKERS, CARDIAC BIOMARKERS, NEUROLOGICAL BIOMARKERS AND CLINICAL ENDPOINTS. OVER 100 PEOPLE ATTENDED, INCLUDING INVESTIGATORS WITH FARA FUNDED BIOMARKER GRANTS AND INDUSTRY PARTNERS. SIGNIFICANT PROGRESS WAS REPORTED. DATA SHOWED ADVANCES IN TECHNOLOGIES TO MEASURE FRATAXIN, NEW TECHNIQUES FOR LOOKING AT CHANGES IN METABOLISM DUE TO FA, DATA ON NOVEL BIOMARKERS OF PERIPHERAL NEUROPATHY SUCH AS MEISSNER CORPUSCLES AND QUANTITATIVE SENSORY TESTING AND NOVEL FLUID BIOMARKERS SUCH AS NEUROFILAMENT LIGHT. PANELS DISCUSSED THE DATA SUPPORTING DIFFERENT NEUROIMAGING BIOMARKERS, AND WHAT THE MOST PROMISING CARDIAC BIOMARKERS MIGHT BE. FINALLY, DATA ON NOVEL GAIT, BALANCE, DEXTERITY AND SPEECH OUTCOME MEASURES WERE SHARED AND DISCUSSED IN THE CONTEXT OF FUNCTIONAL OUTCOME MEASURES.SYMPOSIUMSFARA CO-ORGANIZED THREE PATIENT SYMPOSIUMS WITH CLINICAL RESEARCH NETWORK SITES IN 2018, UNIVERSITY OF CALIFORNIA- LOS ANGELES (FEBRUARY 23), EMORY UNIVERSITY (APRIL 29) AND CHILDREN'S HOSPITAL OF PHILADELPHIA (OCTOBER 15). THESE SYMPOSIUMS PROVIDE AN OPPORTUNITY TO EDUCATE THE PATIENT/FAMILY COMMUNITY ON RESEARCH ADVANCES, PROGRESS ON CLINICAL TRIALS AND ARE A UNIQUE FORUM FOR PATIENTS AND RESEARCHERS TO ENGAGE AND LEARN FROM EACH OTHER'S EXPERIENCES AND PERSPECTIVES. COMBINED THESE SYMPOSIUMS ACCOMMODATED MORE THAN 400 ATTENDEES.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$231,493ExpenseAmt
DescEDUCATION, AWARENESS & OUTREACH PROGRAMSFA IS A RARE DISEASE; AFFECTING 1 IN 50,000 INDIVIDUALS. FARA IS DEDICATED TO RAISING AWARENESS FOR FA. FARA HAS UTILIZED BOTH TRADITIONAL AND SOCIAL MEDIA STRATEGIES TO BRING GREATER AWARENESS TO FA IN THE GENERAL PUBLIC AND TO ENGAGE AND EDUCATE THE FA COMMUNITY. FOR EXAMPLE, FARA CONDUCTED A SOCIAL MEDIA CAMPAIGN THAT ENCOURAGED COMMUNITY PARTICIPATION LEADING UP TO RARE DISEASE DAY AND FA AWARENESS DAY. FARA ALSO HOSTED A FACEBOOK LIVE SERIES TO EDUCATE AND INFORM THE COMMUNITY ABOUT THE LATEST DEVELOPMENTS IN FA RESEARCH AND SOME OF THE RESULTS OF FUNDED GRANTS.THE FARA AMBASSADOR PROGRAM WHICH WAS LAUNCHED IN 2011 WITH >20 PARTICIPANTS HAD A YEAR OF CONTINUED GROWTH AND ACTIVITY IN 2018. THE PROGRAM NOW INCLUDES 65 PARTICIPANTS. THE MISSION OF THE FARA AMBASSADORS IS TO BE POSITIVE, SUPPORTIVE, PEER REPRESENTATIVES FOR THE FA COMMUNITY; ACTIVELY RAISING AWARENESS AND FUNDS FOR FARA.IN 2018, FARA FACILITATED FORMAL TRAINING FOR THE AMBASSADOR LEADERSHIP TEAM AND AMBASSADORS. THE FOCUS FOR THE TRAINING WAS THE FA TREATMENT PIPELINE- THE DEVELOPMENT OF APPROACHES TO TREATING FA. THE AMBASSADOR BLOG FEATURED POSTS SUCH AS COMMUNITY EVENT SUMMARIES, MEET THE COMMUNITY INTERVIEWS WITH PEOPLE LIVING WITH FA, AND PATIENT PERSPECTIVES ON PARTICIPATING IN RESEARCH. IN 2018, THEY ACHIEVED >70 POSTS WITH OVER 27,000 VIEWS. THE AMBASSADORS ALSO CONTINUED A CARD PROGRAM IN WHICH THEY DESIGNED CARDS TO SEND TO THE VARIOUS STAKEHOLDERS AND COMMUNITY MEMBERS THROUGHOUT THE YEAR TO SAY THANK YOU OR TO OFFER ENCOURAGEMENT. THEY ARE AVERAGING ABOUT 20 CARDS PER MONTH. ANOTHER PROJECT FACILITATED BY THE AMBASSADOR GROUP ARE MONTHLY PEER WEBEX HANGOUT GROUPS FOR THE GREATER FA COMMUNITY TO ATTEND AND CONNECT WITH ONE ANOTHER ONLINE (ONE IS GEARED TO ADULTS, AND ONE IS FOR TEENS WITH FA). IN 2018, AMBASSADORS VISITED WITH STUDENTS IN NINE GENETIC COUNSELING PROGRAMS ACROSS THE COUNTRY TO DISCUSS LIVING WITH A RARE, GENETIC DISEASE. FINALLY, THE AMBASSADORS HAVE CONTINUED IMPORTANT OUTREACH IN VISITING ACADEMIC LABORATORIES AND BIOPHARMACEUTICAL COMPANIES TO PROVIDE THE PATIENT PERSPECTIVE OF FA, AND SHARING THEIR PERSONAL EXPERIENCES AT FA SYMPOSIUMS.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$801,223ExpenseAmt
Grant$699,241GrantAmt
DescCLINICAL RESEARCH INFRASTRUCTUREIN ADDITION TO RESEARCH GRANTS FARA FUNDS THE ONGOING DEVELOPMENT OF VITAL CLINICAL RESEARCH INFRASTRUCTURE. CLINICAL RESEARCH INFRASTRUCTURE REFERS TO THE RESOURCES NEEDED TO FACILITATE ANY TYPE OF RESEARCH, INCLUDING CLINICAL TRIALS THAT INVOLVE PATIENTS. THESE RESOURCES CAN INCLUDE THINGS LIKE: FRIEDREICH'S ATAXIA GLOBAL PATIENT REGISTRY: THE ONLY INTERNATIONAL FRIEDREICH ATAXIA PATIENT REGISTRY WITH MORE THAN 3500 INDIVIDUALS ENROLLED. THIS REGISTRY CAPTURES DEMOGRAPHIC AND CLINICAL INFORMATION ON INDIVIDUALS WITH FA AND IS USED TO RECRUIT INDIVIDUALS FOR CLINICAL TRIALS WORLDWIDE. IN 2018, THE PATIENT REGISTRY WAS USED TO RECRUIT FOR 2 CLINICAL TRIALS AND SEVERAL OTHER CLINICAL RESEARCH STUDIES. TO LEARN MORE, VISIT CUREFA.NET/REGISTRY. IN 2018, FARA ENTERED INTO AN AGREEMENT WITH PULSE INFOFRAME FOR THE DEVELOPMENT OF A NEW PATIENT REGISTRY PLATFORM THAT WOULD HAVE EXPANDED RESEARCH AND ANALYTICS CAPABILITIES AND OFFER MULTIPLE LANGUAGES.COLLABORATIVE CLINICAL RESEARCH NETWORK IN FA (CCRN IN FA): AN INTERNATIONAL NETWORK OF 10 CLINICAL RESEARCH CENTERS THAT WORK TOGETHER TO ADVANCE TREATMENTS AND CLINICAL CARE FOR INDIVIDUALS WITH FRIEDREICH'S ATAXIA. HAVING SUCH A NETWORK MEANS THAT THERE ARE TRAINED PHYSICIANS AND RESEARCH COORDINATORS READY TO DO CLINICAL RESEARCH STUDIES AND TRIALS. ALSO, THIS NETWORK IS BACKED BY A DATA COORDINATION CENTER THAT FACILITATES ALL ASPECTS OF DATA COLLECTION, DATABASE MANAGEMENT, AND STATISTICAL ANALYSIS OF STUDY DATA. TO LEARN MORE, VISIT CUREFA.ORG/NETWORK.HTMLNATURAL HISTORY STUDY: LONGITUDINAL DATA (USUALLY ABOUT 10 YEARS) ON INDIVIDUALS WITH A DISEASE THAT DESCRIBES AND QUANTIFIES THE PROGRESSION OF THE DISEASE ALONG WITH THE SYMPTOMS AND MANIFESTATIONS OF THE DISEASE. NATURAL HISTORY CAN SOMETIMES SERVE AS THE BASIS FROM WHICH MEASUREMENTS CAN BE MADE TO DETERMINE EFFECTS OF NEW TREATMENTS, DRUGS OR INTERVENTIONS.CLINICAL OUTCOME MEASURES : FUNCTIONAL PERFORMANCE TESTS (E.G., TIMED PEGBOARD OR WALK TESTS, VISION, HEARING OR SPEECH TESTS) THAT QUANTIFY HOW MUCH CHANGE TAKES PLACE IN A SPECIFIC AMOUNT OF TIME AND ARE USED IN CLINICAL TRIALS TO MEASURE WHETHER A DRUG IS ALTERING THE COURSE OF THE DISEASE.BIOMARKERS: ANYTHING THAT CAN BE USED AS AN INDICATOR OF A PARTICULAR DISEASE STATE - USUALLY PROTEINS, ENZYMES, GENETIC VARIANTS, IMAGING (MRI, CT OR PET SCANS). BIOMARKERS CAN BE USED TO ASSESS RISK OF DISEASE, DIAGNOSIS, OR OUTCOMES. USE OF BIOMARKERS IN DRUG DEVELOPMENT IS OF GREAT INTEREST BECAUSE BIOMARKERS CAN PROVIDE EVIDENCE OF BIOLOGICAL ACTIVITY, POTENTIALLY DEMONSTRATING THERAPEUTIC BENEFIT MORE QUICKLY THAN TRADITIONAL OUTCOME MEASURES. BIOREPOSITORY: A REPOSITORY OR BANK OF STORED BIOLOGICAL MATERIALS SUCH AS BLOOD SAMPLES, DNA, ORGANS, AND TISSUES (SUCH AS SKIN, MUSCLE, HEART) THAT CAN BE USED FOR RESEARCH.THROUGH THE CCRN IN FA WE HAVE COLLECTED NATURAL HISTORY DATA (ONGOING) IN MORE THAN 1,000 INDIVIDUALS WITH FA, VALIDATED CLINICAL OUTCOME MEASURES AND THE FARS SCALE, STUDIED SPEECH, VISION AND HEARING, LAUNCHED BIOMARKER STUDIES, ESTABLISHED DNA AND RNA REPOSITORIES, AND PROVIDED MANY BLOOD SAMPLES TO RESEARCHERS AROUND THE WORLD. THE CCRN IN FA INVESTIGATORS HAVE BEEN INVOLVED IN MULTIPLE CLINICAL TRIALS INCLUDING A FEW THAT WERE DESIGNED AND CONDUCTED SOLELY THROUGH NETWORK SITES. FARA CONTRIBUTED NEARLY $700,000 IN 2018 TO CLINICAL RESEARCH INFRASTRUCTURE IN DIRECT FUNDING TO THE CCRN IN FA CENTERS AND RELATED CLINICAL RESEARCH ACTIVITIES.CRITICAL PATH INSTITUTE DATA COLLABORATION PROJECTIN 2017, FARA INITIATED A PROJECT WITH CRITICAL PATH INSTITUTE'S (C-PATH) DATA COLLABORATION CENTER (DCC) TO DEVELOP AN AGGREGATED DATABASE OF CLINICAL DATA FOR FA. USE OF THIS DATABASE WILL PROMOTE COLLABORATIVE RESEARCH TO SUPPORT THE UNDERSTANDING OF NATURAL HISTORY, POTENTIAL BIOMARKERS, AND POTENTIAL CLINICAL ENDPOINTS FOR PATIENTS WITH FA, WHICH WILL HELP RESEARCHERS DEVELOP MORE EFFICIENT CLINICAL TRIAL PROTOCOLS TO TEST NEW THERAPIES MORE QUICKLY AND EFFECTIVELY. IN 2018, THE PROJECT ESTABLISHED AN INTEGRATED DATABASE OF CLINICAL DATA FOR FA THAT CAN BE SHARED AND UTILIZED BY EXISTING FA RESEARCHERS. IT ENLISTED COMPANIES THAT HAVE CARRIED OUT CLINICAL TRIALS IN FA TO OBTAIN CONTRIBUTIONS OF CLINICAL DATA, AS WELL AS SHARING NATURAL HISTORY DATA COLLECTED BY FARA'S COLLABORATIVE CLINICAL RESEARCH NETWORK.THREE DE-IDENTIFIED DATASETS FROM PREVIOUS CLINICAL TRIALS AND FOUR FA-CLINICAL OUTCOME MEASURE DATASETS HAVE BEEN AGGREGATED INTO A SINGLE DATABASE IN A SCIENTIFICALLY RIGOROUS MANNER BY C-PATH'S DCC.ADDITIONAL INFORMATION ABOUT FARA'S PROGRAMS IN 2018 CAN BE ACCESSED VIA THE ANNUAL REPORT AT: CUREFA.ORG/FINANCIALSDesc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$801,223TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$699,241TotalOtherProgSrvcGrantAmt
Total Program Service Expenses$6,809,700TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related InvstYes (1)ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J Required0ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer EntYes (1)BusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document3IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee13EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed OfYes (1)Form8282PropertyDisposedOfInd
Form8282 Filed1Form8282FiledCnt
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members18GoverningBodyVotingMembersCnt
Independent Voting Member16IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1JENNIFER FARMERBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone4848796160PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1533 W UWCHLAN AVENUEAddressLine1Txt
CityDOWNINGTOWNCityNm
State AbbreviationPAStateAbbreviationCd
ZIP19335ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (19 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerInd
EDWARD RAMSEY
DIRECTOR0.00Yes (X)$0$0$0
MARILYN E DOWNING
SECRETARY0.00Yes (X)$0$0$0Yes (X)
RUTH ACTON
TREASURER25.00Yes (X)$10,000$0$0Yes (X)
JENNIFER GOOD
DIRECTOR0.00Yes (X)$0$0$0
PAUL AVERY
CHAIRMAN0.00Yes (X)$0$0$0Yes (X)
DR HOLLY HEDRICK
DIRECTOR0.00Yes (X)$0$0$0
GEOFFREY LEVITT
DIRECTOR0.00Yes (X)$0$0$0
DR STEVE KLASKO
DIRECTOR0.00Yes (X)$0$0$0
THOMAS HAMILTON
DIRECTOR0.00Yes (X)$0$0$0
BERNARD RAVINA
SCIENTIFIC DIRECTOR0.00Yes (X)$0$0$0
DR SANJAY BIDICHANDANI
SCIENTIFIC DIRECTOR0.00Yes (X)$0$0$0
DEREK G HENNECKE
DIRECTOR0.00Yes (X)$0$0$0
DR JAMES MCARTHUR
SCIENTIFIC DIRECTOR0.00Yes (X)$0$0$0
TONY PLOHOROS
DIRECTOR0.00Yes (X)$0$0$0
PAT RITSCHEL
DIRECTOR0.00Yes (X)$0$0$0
RONALD BARTEK
PRESIDENT/DIRECTOR40.00Yes (X)$100,000$0$3,172Yes (X)
BRIGID BRENNAN
DIRECTOR0.00Yes (X)$0$0$0
DR JAMES R RUSCHE
DIRECTOR0.00Yes (X)$0$0$0
JENNIFER FARMER
EXECUTIVE DIRECTOR40.00$130,000$0$4,109Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$240,000TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$7,281TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K1IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K0TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
Federated Campaigns$25,510FederatedCampaignsAmt
Fundraising$4,365,045FundraisingAmt
All Other Contributions$3,272,070AllOtherContributionsAmt
Noncash Contributions$6,944NoncashContributionsAmt
Total Contributions$7,662,625TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$42,296TotalRevenueColumnAmt
Exclusion$42,296ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$342,637SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$344,399SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$1,762SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$1,762TotalRevenueColumnAmt
Exclusion-$1,762ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$775,861FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$4,365,045ContriRptFundraisingEventAmt
Fundraising Direct Expenses$875,475FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$99,614TotalRevenueColumnAmt
Exclusion-$99,614ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$7,603,545TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion-$59,080ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$4,675,310TotalAmt
Program Services$4,675,310ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$1,403,352TotalAmt
Program Services$1,403,352ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$256,880TotalAmt
Program Services$199,506ProgramServicesAmt
Management And General$33,440ManagementAndGeneralAmt
Fundraising$23,934FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$408,961TotalAmt
Program Services$330,078ProgramServicesAmt
Management And General$28,734ManagementAndGeneralAmt
Fundraising$50,149FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$13,200TotalAmt
Management And General$13,200ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$14,069TotalAmt
Management And General$14,069ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$43,286TotalAmt
Program Services$33,750ProgramServicesAmt
Management And General$3,536ManagementAndGeneralAmt
Fundraising$6,000FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$1,426TotalAmt
Program Services$1,406ProgramServicesAmt
Fundraising$20FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$15,007TotalAmt
Program Services$4,683ProgramServicesAmt
Management And General$6,471ManagementAndGeneralAmt
Fundraising$3,853FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$28,025TotalAmt
Program Services$16,014ProgramServicesAmt
Management And General$4,004ManagementAndGeneralAmt
Fundraising$8,007FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$88,788TotalAmt
Program Services$80,598ProgramServicesAmt
Management And General$8,180ManagementAndGeneralAmt
Fundraising$10FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$54,576TotalAmt
Program Services$44,398ProgramServicesAmt
Management And General$10,178ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$500TotalAmt
Management And General$500ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$2,816TotalAmt
Management And General$2,816ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
BOOKS, SUBSCRIPTIONS &$17,557$9,125$1,707$6,725
MISCELLANEOUS$6,940$5,047$1,838$55
BUSINESS REGISTRATION F$6,481$517$5,964
CREDIT CARD & BANK FEES$6,347$948$211$5,188

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$6,331TotalAmt
Program Services$5,485ProgramServicesAmt
Management And General$846ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$7,049,852TotalAmt
Program Services$6,809,700ProgramServicesAmt
Management And General$130,247ManagementAndGeneralAmt
Fundraising$109,905FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,459,689BOYAmt
EOY$2,162,521EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$230,051BOYAmt
EOY$0EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$358,567BOYAmt
EOY$195,821EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$8,402BOYAmt
EOY$37,323EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$7,135LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$6,629LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,006BOYAmt
EOY$506EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$1,703,763BOYAmt
EOY$1,620,731EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$1,091,500BOYAmt
EOY$1,091,500EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$4,852,978BOYAmt
EOY$5,108,402EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$323,194BOYAmt
EOY$130,166EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$323,194BOYAmt
EOY$130,166EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$4,208,302BOYAmt
EOY$4,914,855EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$321,482BOYAmt
EOY$63,381EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$4,529,784BOYAmt
EOY$4,978,236EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$4,852,978BOYAmt
EOY$5,108,402EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$553,693ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$97,572NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets-$7,669OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,572,073CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,701,123CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,388,847CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$7,518,776CurrentTaxYearMinus1YearAmt
Current Tax Year$7,662,625CurrentTaxYearAmt
Total$31,843,444TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,572,073CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,701,123CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,388,847CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$7,518,776CurrentTaxYearMinus1YearAmt
Current Tax Year$7,662,625CurrentTaxYearAmt
Total$31,843,444TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$3,335,773SubstantialContributorsTotAmt
Public Support Total170$28,507,671PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$14,051CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$19,755CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$29,213CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$37,283CurrentTaxYearMinus1YearAmt
Current Tax Year$42,296CurrentTaxYearAmt
Total$142,598TotalAmt
FieldValueIRS element (for citing)
Total Support$31,986,042TotalSupportAmt
Public Support CY1700.89130PublicSupportCY170Pct
Public Support PY1700.87750PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Section4955 Organization Tax$0Section4955OrganizationTaxAmt
Section4955 Managers Tax$0Section4955ManagersTaxAmt

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$5,326FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$3,599FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$8,925FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$6,625,747FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$6,634,672FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$481,734FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$120,434FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$458,529CurrentYearMinus3Amt
Current Year Minus2$465,526CurrentYearMinus2Amt
Current Year Minus1$531,374CurrentYearMinus1Amt
Current Year$481,734CurrentYearAmt
Total$1,937,163TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$2,905,745LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$8,106CurrentYearMinus3Amt
Current Year Minus2$6,200CurrentYearMinus2Amt
Current Year Minus1$6,500CurrentYearMinus1Amt
Current Year$8,925CurrentYearAmt
Total$29,731TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$114,632CurrentYearMinus3Amt
Current Year Minus2$116,382CurrentYearMinus2Amt
Current Year Minus1$132,844CurrentYearMinus1Amt
Current Year$120,434CurrentYearAmt
Total$484,292TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$726,438GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$4,731CurrentYearMinus3Amt
Current Year Minus2$3,700CurrentYearMinus2Amt
Current Year Minus1$3,879CurrentYearMinus1Amt
Current Year$5,326CurrentYearAmt
Total$17,636TotalAmt

Schedule D IRS990ScheduleD

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$7,135OtherCostOrOtherBasisAmt
Depreciation$6,629DepreciationAmt
Book Value$506BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$506TotalBookValueLandBuildingsAmt

Invst Program Related Org InvstProgramRelatedOrgGrp

FieldValueIRS element (for citing)
DescINVESTMENT IN BIOELECTRON TECHNOLOGY CORPORATIONDesc
Book Value$1,091,500BookValueAmt
Method ValuationCMethodValuationCd
FieldValueIRS element (for citing)
Total Book Value Program Rltd$1,091,500TotalBookValueProgramRltdAmt
Total Rev Etc Audited Fincl Stmt$8,359,710TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$97,572NetUnrealizedGainsInvstAmt
Other Revenue$875,475OtherRevenueAmt
Revenue Not Reported$777,903RevenueNotReportedAmt
Revenue Subtotal$7,581,807RevenueSubtotalAmt
Other Revenues Not Included$21,738OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$21,738RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$7,603,545TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$7,911,258TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$875,475OtherExpensesIncludedAmt
Expenses Not Reported$875,475ExpensesNotReportedAmt
Expenses Subtotal$7,035,783ExpensesSubtotalAmt
Other Expenses Not Included$14,069OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$14,069ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$7,049,852TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART XI, LINE 2D - OTHER ADJUSTMENTS:SPECIAL EVENTS EXPENSE
PART XI, LINE 4B - OTHER ADJUSTMENTS:INVESTMENT MANAGEMENT FEES MISC. DONATED ITEMS MISC REVENUE
PART XII, LINE 2D - OTHER ADJUSTMENTS:SPECIAL EVENTS EXPENSE
PART XII, LINE 4B - OTHER ADJUSTMENTS:INVESTMENT MANAGEMENT FEES

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)

RegionRegionTxtType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EUROPEGRANTS TO RECIPIENTS LOCATED IN REGIONRESEARCH AND GRANT PROGRAM$977,755
EAST ASIA AND THE PACIFICGRANTS TO RECIPIENTS LOCATED IN REGIONRESEARCH AND GRANT PROGRAM$373,747
SOUTH AMERICAGRANTS TO RECIPIENTS LOCATED IN REGIONRESEARCH AND GRANT PROGRAM$51,850
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$1,403,352SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$1,403,352TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (12 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
EAST ASIA AND THE PACIFICMEDICAL RESEARCH$164,129WIRE
EUROPEMEDICAL RESEARCH$57,602WIRE
EUROPEMEDICAL RESEARCH$140,277WIRE
EUROPEMEDICAL RESEARCH$250,000WIRE
SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR,MEDICAL RESEARCH$51,850WIRE
EUROPEMEDICAL RESEARCH$98,500WIRE
EUROPEMEDICAL RESEARCH$27,500WIRE
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,MEDICAL RESEARCH$117,822WIRE
EUROPEMEDICAL RESEARCH$178,903WIRE
EAST ASIA AND THE PACIFICMEDICAL RESEARCH$91,796WIRE
EUROPEMEDICAL RESEARCH$75,000
EUROPEMEDICAL RESEARCH$149,973
FieldValueIRS element (for citing)
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationGRANTS ARE REVIEWED BY INDEPENDENT SCIENTIFIC ADVISORS AND APPROVED BY BOARD. ONCE GRANTS ARE AWARDED THE ORGANIZATION REQUIRES REGULAR RESEARCH AND FINANCIAL REPORTS FROM THE INSTITUTIONS.ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1FARA ENERGY BALLEvent1Nm
Gross Receipts Event1$2,369,232GrossReceiptsEvent1Amt
Charitable Contri Event1$1,886,949CharitableContriEvent1Amt
Gross Revenue Event1$482,283GrossRevenueEvent1Amt
Other Direct Expenses Event1$382,651OtherDirectExpensesEvent1Amt
Event2RIDE ATAXIA PHILADELPHIAEvent2Nm
Gross Receipts Event2$417,953GrossReceiptsEvent2Amt
Charitable Contri Event2$389,053CharitableContriEvent2Amt
Gross Revenue Event2$28,900GrossRevenueEvent2Amt
Other Direct Expenses Event2$52,714OtherDirectExpensesEvent2Amt
Other Events Total61OtherEventsTotalCnt
Gross Receipts Other Events$2,353,721GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$2,089,043CharitableContriOtherEventsAmt
Gross Revenue Other Events$264,678GrossRevenueOtherEventsAmt
Oth Direct Expnss Other Events$440,110OthDirectExpnssOtherEventsAmt
Gross Receipts Total$5,140,906GrossReceiptsTotalAmt
Charitable Contributions Tot$4,365,045CharitableContributionsTotAmt
Gross Revenue Total Events$775,861GrossRevenueTotalEventsAmt
Oth Direct Expnss Total Events$875,475OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$875,475DirectExpenseSummaryEventsAmt
Net Income Summary-$99,614NetIncomeSummaryAmt
FieldValueIRS element (for citing)
Individual With BooksFELICIA DEROSAIndividualWithBooksNm

Persons With Books US Address PersonsWithBooksUSAddress

FieldValueIRS element (for citing)
Address Line1533 W UWCHLAN AVENUEAddressLine1Txt
CityDOWNINGTOWNCityNm
State AbbreviationPAStateAbbreviationCd
ZIP19335ZIPCd

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (27 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
CHILDREN'S HOSPITAL OF PHILADELPHIA
34TH ST CIVIC CENTER BLVDPHILADELPHIAPA19104231352166501(C)(3)$1,606,300MEDICAL RESEARCH
EMORY UNIVERSITY
201 DOWMAN DRATLANTAGA30322580566256501(C)(3)$24,200MEDICAL RESEARCH
OHIO STATE UNIVERSITY
333 W 10TH AVECOLUMBUSOH43210316025986501(C)(3)$5,300MEDICAL RESEARCH
REGENTS OF THE UNIVERSITY OF MINNESOTA
200 SE OAK ST 600MINNEAPOLISMN55455416007513501(C)(3)$112,319MEDICAL RESEARCH
SCRIPPS RESEARCH INSTITUTE
10550 NORTH TORREY PINES ROADLA JOLLACA92037330435954501(C)(3)$71,587MEDICAL RESEARCHOSP-TPC7
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES
10920 WILSHIRE BLVD 5TH FLOORLOS ANGELESCA90024956006143501(C)(3)$79,200MEDICAL RESEARCH
UNIVERSITY OF FLORIDA
DEPT OF NEUROLOGY L3-100 MCKNIGHTGAINESVILLEFL32611596002052501(C)(3)$383,420MEDICAL RESEARCHBRAIN INSTITUTE NEWELL DRIVE
UNIVERSITY OF IOWA DEPT OF PEDIATRICS
200 HAWKINS DRIVEIOWA CITYIA52242426004813501(C)(3)$11,400MEDICAL RESEARCH
UNIVERSITY OF ROCHESTER
515 HYLAN BUILDING RC BOX 270140ROCHESTERNY14627160743209501(C)(3)$314,074MEDICAL RESEARCH
ALBANY RESEARCH INSTITUTE
113 HOLLAND AVEALBANYNY12208141716021501(C)(3)$80,750MEDICAL RESEARCH
THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
5323 HARRY HINES BLVDDALLASTX75390756002868501(C)(3)$124,698MEDICAL RESEARCH
UNIVERSITY OF SOUTH FLORIDA
4202 EAST FOWLER AVENUETAMPAFL33620593102112501(C)(3)$10,374MEDICAL RESEARCH
BAYLOR COLLEGE OF MEDICINE
1 BAYLOR PLAZAHOUSTONTX77030741613878501(C)(3)$250,000MEDICAL RESEARCH
Q-STATE BIOSCIENCES INC
179 SIDNEY STCAMBRIDGEMA02139462469775$33,578MEDICAL RESEARCH
UNIVERSITY OF MASSACHUSETTS
1 CAMPUS CENTER WAYAMHERSTMA01003542084125501(C)(3)$323,865MEDICAL RESEARCH
UNIVERSITY OF VIRGINIA
580 MASSIE ROADCHARLOTTESVILLEVA22901546001796501(C)(3)$125,000MEDICAL RESEARCH
UNIVERSITY OF WISCONSIN
1308 W DAYTON STREETMADISONWI53706396006492501(C)(3)$89,769MEDICAL RESEARCH
ARIZONA STATE UNIVERSITY
1151 S FOREST AVETEMPEAZ85287860196696501(C)(3)$150,000MEDICAL RESEARCH
COLUMBIA UNIVERSITY
116TH STREET BROADWAYNEW YORKNY10027135598093501(C)(3)$150,000MEDICAL RESEARCH
NATIONAL ATAXIA FOUNDATION
600 HIGHWAY 169 S STE 1725MINNEAPOLISMN55426410832903501(C)(3)$5,000MEDICAL RESEARCH
PRESIDENT AND FELLOWS OF HARVARD
1563 MASSACHUSETTS AVECAMBRIDGEMA02138042103580501(C)(3)$88,064MEDICAL RESEARCH
UNIVERSITY OF UTAH
201 PRESIDENTS CIRCLESALT LAKE CITYUT84112876000525501(C)(3)$300,000MEDICAL RESEARCH
THOMAS JEFFERSON UNIVERSITY
4201 HENRY AVEPHILADELPHIAPA19144231352294501(C)(3)$2,000MEDICAL RESEARCH
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT ST RM 310PHILADELPHIAPA19104231352685501(C)(3)$150,000MEDICAL RESEARCH
UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVELA JOLLACA92093956006144501(C)(3)$150,000MEDICAL RESEARCH
UNIVERSITY OF COLORADO
20 UCBBOULDERCO80309846000555501(C)(3)$7,500MEDICAL RESEARCH
UNIVERSITY OF ALABAMA- BIRMINGHAM
1720 2ND AVE SBIRMINGHAMAL35294636005396501(C)(3)$26,912MEDICAL RESEARCH

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationGRANTS ARE REVIEWED BY INDEPENDENT SCIENTIFIC ADVISORS AND APPROVED BY BOARD. ONCE GRANTS ARE AWARDED THE ORGANIZATION REQUIRES REGULAR RESEARCH AND FINANCIAL REPORTS FROM THE INSTITUTIONS.ExplanationTxt

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

FieldValueIRS element (for citing)
PersonTHOMAS HAMILTONPersonNm
FieldValueIRS element (for citing)
Relationship DescriptionBOARD MEMBERRelationshipDescriptionTxt
Transaction$1,599,543TransactionAmt
TransactionCONTRIBUTIONS FROM BOARD MEMBER'S ORGANIZATION (CUREFA) TO FRIEDREICH'S ATAXIA RESEARCH ALLIANCE TO SUPPORT RESEARCH AND GRANT PROGRAMS.TransactionDesc
Sharing Of Revenues0SharingOfRevenuesInd

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution6ContributionCnt
Noncash Contributions Rpt F990$391,575NoncashContributionsRptF990Amt
Method Of Determining RevenuesMARKET PRICEMethodOfDeterminingRevenuesTxt

Food Inventory FoodInventoryGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution1ContributionCnt
Noncash Contributions Rpt F990$6,944NoncashContributionsRptF990Amt
Method Of Determining RevenuesCOST OF MEATMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received1Form8283ReceivedCnt
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts0ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION B, LINE 11BCOPIES OF 990 ARE DISTRIBUTED TO BOARD MEMBERS FOR REVIEW AND APPROVAL PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12CALL NEW AND EXISTING BOARD MEMBERS REQUIRED TO ANNUALLY COMPLETE A CONFLICT OF INTEREST STATEMENT
FORM 990, PART VI, SECTION B, LINE 15EVALUATION AND COMPENSATION COMMITTEE PERFORMS EMPLOYEE EVALUATIONS AND DETERMINES SALARY INCREASES ON A YEARLY BASIS FOR ALL EMPLOYEES. COMMITTEE EXAMINES BENCHMARK DATA IN DETERMINING SALARIES FOR PRESIDENT AND EXECUTIVE DIRECTOR.
FORM 990, PART VI, SECTION C, LINE 18FORM 990 IS AVAILABLE ON THE ORGANIZATION'S WEBSITE AS WELL AS GUIDESTAR.ORG AND CHARITYNAVIGATOR.ORG
FORM 990, PART VI, SECTION C, LINE 19FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FORM 1023 ARE AVAILABLE UPON REQUEST.
FORM 990, PART XI, LINE 9:FOOD INVENTORY CONSUMED -6,944. MISC REVENUE -725.
FORM 990, PART XII, LINE 2CFARA'S AUDIT COMMITTEE CONSISTS OF THE FINANCE COMMITTEE, EXECUTIVE DIRECTOR AND ONE AT-LARGE BOARD MEMBER. EACH YEAR THE AUDIT COMMITTEE SEEKS THE SERVICES OF AN OUTSIDE ACCOUNTING FIRM AND CONTRACTS FOR A FULL AUDIT, PREPARATION OF FINANCIAL STATEMENTS AND FILING OF THE 990. THE AUDIT COMMITTEE IS RESPONSIBLE FOR REVIEWING RECOMMENDATIONS FROM THE AUDIT AND PROPOSING NEW POLICIES AND PROCEDURES AS NECESSARY. THE AUDIT COMMITTEE ALSO PARTICIPATES IN DETAILED REVIEW OF FINANCIAL STATEMENTS AND 990 PRIOR TO SHARING WITH THE FULL BOARD FOR A VOTE. FARA'S BOARD OF DIRECTORS RECEIVES THE FINANCIAL STATEMENTS AND 990 FOR REVIEW AND VOTES TO APPROVE PRIOR TO PUBLIC FILING.